
englanti
Teknologia & tieteet
Rajoitettu tarjous
Sitten 7,99 € / kuukausiPeru milloin tahansa.
Lisää Solutions OP Clinical Trials UK
This podcast is dedicated to clinical trials and clinical research. We will be discussing different hot topics and analysis of the latest developments in clinical trials in pharmaceutical and medical devices industries. We have interviews with different industry experts.New episodes will be available every 2 weeks.
How to engage more patients in clinical trials: Interview With Keith Berelowitz
In this episode of the podcast we are discussing patients engagement in clinical trial with Keith Berelowitz, who is the chair of Fulham Ethics Committee and entrepreneur working on a new AI powered platform aiming to improve recruitment in clinical trials. Apart from discussing how their platform pRxEngage operates we are also talking about the main challenges in recruiting patients in clinical trials and what could be done to improve reach out to different communities. You can read the transcript of our interview here: https://solutionsop.co.uk/2025/11/14/how-to-engage-more-patients-in-clinical-trials-interview-with-keith-berelowitz/ [https://solutionsop.co.uk/2025/11/14/how-to-engage-more-patients-in-clinical-trials-interview-with-keith-berelowitz/]
The Role Of Nurse Practitioners In Clinical Research: Interview With Steven Edmunds
In this episode we are talking to Steven Edmunds, who is advanced nurse practitioner at Royal Marsden Hospital in London, UK. The focus of our discussion is the role of the nurse practitioners in clinical research but also as a career opportunity for experienced and knowledgeable research nurses looking to take on more responsibilities. You will be able to read the transcript of our discussion here: https://solutionsop.co.uk/2025/10/31/the-role-of-nurse-practitioners-in-clinical-research-interview-with-steven-edmunds/ [https://solutionsop.co.uk/2025/10/31/the-role-of-nurse-practitioners-in-clinical-research-interview-with-steven-edmunds/]
Why Is The UK Losing The Big Pharma Investment
This episode covers the latest developments in the UK life science sector where some big pharma companies are pausing investment or cancelling their investment projects. The analysis touches on the international situation and country specific problems which led to these consequences.
Is The FDA Chemistry Manufacturing Controls Pilot Program Helpful For Pharma Startups?
This episode is an overview of the FDA Chemistry Manufacturing Controls Pilot Program and lessons learnt from the current participants in the pilot. It covers what is the scope of the pilot program and some of the unique challenges in manufacturing. Would that pilot be useful for small pharma companies and startups? You can read our transcript here: https://solutionsop.co.uk/2025/10/09/is-the-fda-chemistry-manufacturing-controls-pilot-program-helpful-for-pharma-startups/ [https://solutionsop.co.uk/2025/10/09/is-the-fda-chemistry-manufacturing-controls-pilot-program-helpful-for-pharma-startups/]
Finding Your First Job In Clinical Research: Discussion with Harry Henson
In this episode we are discussing the current challenges in the clinical research job market with the experienced recruiter, Harry Henson. He shares with us his advices for young job seekers who are looking to find their first job in clinical research after graduating school or university. Transcript of this interview is available here: https://solutionsop.co.uk/2025/10/01/finding-your-first-job-in-clinical-research-discussion-with-harry-henson/ [https://solutionsop.co.uk/2025/10/01/finding-your-first-job-in-clinical-research-discussion-with-harry-henson/]
Valitse tilauksesi
Rajoitettu tarjous
Premium
Podimon podcastit
Lataa offline-käyttöön
Peru milloin tahansa
3 kuukautta hintaan 1 €
Sitten 7,99 € / kuukausi
Premium
20 tuntia äänikirjoja
Podimon podcastit
Lataa offline-käyttöön
Peru milloin tahansa
30 vrk ilmainen kokeilu
Sitten 9,99 € / kuukausi
Premium
100 tuntia äänikirjoja
Podimon podcastit
Lataa offline-käyttöön
Peru milloin tahansa
30 vrk ilmainen kokeilu
Sitten 19,99 € / kuukausi
3 kuukautta hintaan 1 €. Sitten 7,99 € / kuukausi. Peru milloin tahansa.